UNC to Test Injectable Long-Acting Implant to Prevent HIV

Researchers at the University of North Carolina at Chapel Hill have received a three-year, $1.8 million grant from the National Institutes of Health to develop a new implantable drug delivery system for long-lasting HIV-prevention. Scientists in the UNC School of Medicine’s Division of Infectious Diseases and the UNC Eshelman School of Pharmacy are developing an… Read More

HIV DART 2014: “Frontiers in Drug Development for Antiretroviral Therapies”

HIV DART 2014 Conference: “Frontiers in Drug Development for Antiretroviral Therapies” December 9-12, 2014, Los Cabos, Mexico The focus of HIV DART 2014 is to assemble clinicians, nurses, researchers and basic scientists together to advance our knowledge of the ongoing drug development processes in antiretroviral research. This conference will uniquely blend the areas of biology,… Read More

Friday ID Conference: Dynamics and Clinical Relevance of Drug Resistant HIV

This talk is a part of our friday morning CFAR/IGHID Friday ID Conference Series. “Dynamics and Clinical Relevance of Drug Resistant HIV; the end of the problem” Speaker: Charles Boucher MD, PhD Erasmus University Rotterdam, The Netherlands September 12, 2014 8:30 – 9:30 a.m. 1131 Bioinformatics (first floor auditorium), UNC-CH Campus Charles Boucher is Professor… Read More